Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy ; volume:9 ; number:1 ; day:5 ; month:2 ; year:2018 ; pages:1-15 ; date:12.2018
Stem cell research & therapy ; 9, Heft 1 (5.2.2018), 1-15, 12.2018
- Urheber
-
Silva dos Santos, Danúbia
- Beteiligte Personen und Organisationen
-
Brasil, Guilherme Visconde
Ramos, Isalira Peroba Rezende
Mesquita, Fernanda Cristina Paccola
Kasai-Brunswick, Tais Hanae
Christie, Michelle Lopes Araújo
Cahli, Gustavo Monnerat
Barbosa, Raiana Andrade Quintanilha
da Cunha, Sandro Torrentes
Pereira, Jonathas Xavier
Medei, Emiliano
Campos de Carvalho, Antonio Carlos
Carvalho, Adriana Bastos
Goldenberg, Regina Coeli dos Santos
SpringerLink (Online service)
- DOI
-
10.1186/s13287-018-0788-2
- URN
-
urn:nbn:de:1111-201804019309
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Silva dos Santos, Danúbia
- Brasil, Guilherme Visconde
- Ramos, Isalira Peroba Rezende
- Mesquita, Fernanda Cristina Paccola
- Kasai-Brunswick, Tais Hanae
- Christie, Michelle Lopes Araújo
- Cahli, Gustavo Monnerat
- Barbosa, Raiana Andrade Quintanilha
- da Cunha, Sandro Torrentes
- Pereira, Jonathas Xavier
- Medei, Emiliano
- Campos de Carvalho, Antonio Carlos
- Carvalho, Adriana Bastos
- Goldenberg, Regina Coeli dos Santos
- SpringerLink (Online service)
Ähnliche Objekte (12)
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
LncRNA GHET1 from bone mesenchymal stem cell–derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3
Doxorubicin-induced ovarian toxicity
Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Major vault protein attenuates cardiomyocyte injury in doxorubicin-induced cardiomyopathy through activating AKT
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Human induced pluripotent stem cell models used in the study of doxorubicin-induced cardiomyopathy
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
LncRNA GHET1 from bone mesenchymal stem cell–derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3
Doxorubicin-induced ovarian toxicity
Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Major vault protein attenuates cardiomyocyte injury in doxorubicin-induced cardiomyopathy through activating AKT
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Human induced pluripotent stem cell models used in the study of doxorubicin-induced cardiomyopathy
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
LncRNA GHET1 from bone mesenchymal stem cell–derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3
Doxorubicin-induced ovarian toxicity
Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Major vault protein attenuates cardiomyocyte injury in doxorubicin-induced cardiomyopathy through activating AKT
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction